Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
World

UNCOVERED: The 70 billion shot in the dark - The Untold Story

As demand for weight-loss drugs explodes, a dangerous shadow market of counterfeits, foreign generics, and underground peptides is quietly putting patients at risk. Big Pharma is fighting back. So far, with limited success.

The numbers are staggering. The global market for drugs like Ozempic, Wegovy, Mounjaro and Zepbound was worth roughly $70 billion in 2025 and is projected by JP Morgan to exceed $200 billion by 2030. More than 40 percent of American adults are classified as obese. Roughly 30 million live with Type 2 diabetes. One in eight American adults has already used a GLP-1 drug, according to KFF.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.